Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
- PMID: 28350011
- PMCID: PMC5368596
- DOI: 10.1038/srep45293
Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
Abstract
Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and assessed clinicopathological information, together with data from 15 published studies, totalling 1984 cases. By immunohistochemistry we investigated 14 biomarkers (ERα, ERβ1, ERβ2, ERβ5, PR, AR, Bcl-2, HER2, p53, E-cadherin, Ki67, survivin, prolactin, FOXA1) for survival impact. The main histological subtype in our cohort and combined analyses was ductal (81%, 83%), grade 2; (40%, 44%), respectively. Cases were predominantly ERα (84%, 82%) and PR positive (74%, 71%), respectively, with HER2 expression being infrequent (2%, 10%), respectively. In our cohort, advanced age (>67) was the strongest predictor of overall (OS) and disease free survival (DFS) (p = 0.00001; p = 0.01, respectively). Node positivity negatively impacted DFS (p = 0.04). FOXA1 p = 0.005) and AR p = 0.009) were both positively prognostic for DFS, remaining upon multivariate analysis. Network analysis showed ERα, AR and FOXA1 significantly correlated. In summary, the principle phenotype of MBC was luminal A, ductal, grade 2. In ERα+ MBC, only AR had prognostic significance, suggesting AR blockade could be employed therapeutically.
Conflict of interest statement
The authors declare no competing financial interests.
Figures


Similar articles
-
Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment.Eur J Endocrinol. 2014 Oct;171(4):527-33. doi: 10.1530/EJE-14-0278. Epub 2014 Jul 28. Eur J Endocrinol. 2014. PMID: 25069458
-
Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.Clin Cancer Res. 2008 Aug 15;14(16):5228-35. doi: 10.1158/1078-0432.CCR-07-4528. Clin Cancer Res. 2008. PMID: 18698041
-
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21. doi: 10.1158/1078-0432.CCR-07-0122. Clin Cancer Res. 2007. PMID: 17671124
-
Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancer.Breast Cancer. 2015 Sep;22(5):520-8. doi: 10.1007/s12282-013-0515-x. Epub 2014 Jan 11. Breast Cancer. 2015. PMID: 24415069
-
BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.Clin Cancer Res. 2003 Oct 1;9(12):4452-9. Clin Cancer Res. 2003. PMID: 14555518
Cited by
-
Exploring the One Health Paradigm in Male Breast Cancer.J Mammary Gland Biol Neoplasia. 2024 Apr 4;29(1):8. doi: 10.1007/s10911-024-09560-6. J Mammary Gland Biol Neoplasia. 2024. PMID: 38573417 Free PMC article. Review.
-
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.Ann Oncol. 2018 Feb 1;29(2):405-417. doi: 10.1093/annonc/mdx651. Ann Oncol. 2018. PMID: 29092024 Free PMC article.
-
Male breast cancer in a single-center experience: Diagnosis, clinicopathological features, and treatment strategies.North Clin Istanb. 2024 Oct 2;11(5):434-439. doi: 10.14744/nci.2024.32815. eCollection 2024. North Clin Istanb. 2024. PMID: 39431041 Free PMC article.
-
The prediction of distant metastasis risk for male breast cancer patients based on an interpretable machine learning model.BMC Med Inform Decis Mak. 2023 Apr 21;23(1):74. doi: 10.1186/s12911-023-02166-8. BMC Med Inform Decis Mak. 2023. PMID: 37085843 Free PMC article.
-
Integrated analysis of label-free quantitative proteomics and bioinformatics reveal insights into signaling pathways in male breast cancer.Genet Mol Biol. 2021 Mar 1;44(1):e20190410. doi: 10.1590/1678-4685-GMB-2019-0410. eCollection 2021. Genet Mol Biol. 2021. PMID: 33656060 Free PMC article.
References
-
- Giordano S., Cohen D., Buzdar A., Perkins G. & Hortobagyi G. Breast carcinoma in men: a population-based study. Cancer 101, 51–57 (2004). - PubMed
-
- CRUK. Breast cancer incidence in males. Available: http://www.cancerresearchuk.org/health-professional/cancer-statistics/st... Accessed: 18 Aug 2016 (2014).
-
- American Cancer Society: Cancer Facts and Figures 2014. Atlanta, Ga: Avaliable from: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/... Accessed 19 Aug 2016. (American Cancer Society 2014).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous